Lamivudine Catalog No.:M9256-10 Strategies and Advancement in Antibody-Drug

Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted CancerTherapeutics

InChiKey: MKMPWKUAHLTIBJ-ISTRZQFTSA-N

Smiles: CC(C)(C)[C@H](NC(=O)CCCCCC(=O)N1CCN(CC[C@H](CSC2C=CC=CC=2)NC2=CC=C(C=C2S(=O)(=O)C(F)(F)F)S(=O)(=O)NC(=O)C2C=CC(=CC=2)N2CCN(CC2)CC2CC(C)(C)CCC=2C2C=CC(Cl)=CC=2)CC1)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)C1C=CC(=CC=1)C1SC=NC=1C

SGK3-PROTAC1 suppresses proliferation of ZR-75-1 and CAMA-1 cancer cell lines treated with a PI3K inhibitor more effectively than could be achieved by a conventional SGK isoform inhibitor

Oral dosing of GNF7156 in diabetic mice induces β-cell proliferation

Lamivudine Catalog No.:M9256-10 Strategies and Advancement in Antibody-DrugLamivudine is an antiretroviral medication used to prevent and treat HIV AIDS and used to treat chronic hepatitis B. It is of the nucleoside analog reverse transcriptase inhibitor (NRTI) class. Lamivudine is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system. Product information CAS Number: 134678 17 4 Molecular Weight: 229. 26 Formula: C8H11N3O3S Synonym: 3TC Epivir